Ribbon Health vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 35)
Ribbon Health logo

Ribbon Health

EmergingHealthTech

Provider Data API

Ribbon Health provides an API for accurate, real-time provider data — physician directories, insurance acceptance, and location details — helping health plans and apps build reliable care navigation.

AI VisibilityBeta
Overall Score
D35
Category Rank
#543 of 596
AI Consensus
82%
Trend
stable
Per Platform
ChatGPT
39
Perplexity
38
Gemini
40

About

Ribbon Health aggregates and continuously cleans provider data — physician names, specialties, practice locations, insurance plans accepted, and availability — and delivers it through an API that health technology companies, payers, and health systems use to build accurate provider directories and care navigation tools. The core problem Ribbon solves is that provider data decays rapidly as doctors change practices, update insurance contracts, and open or close locations, making directory accuracy a persistent challenge across the industry.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

35
Overall Score
90
#543
Category Rank
#2
82
AI Consensus
83
stable
Trend
stable
39
ChatGPT
92
38
Perplexity
93
40
Gemini
89
40
Claude
96
33
Grok
95

Key Details

Category
Provider Data API
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Ribbon Health
Provider Data API

Integrations

Only Moderna
Moderna is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.